Author: A. Ant, CADC-II, Licensing & Accreditation Expert
Massachusetts Drug and Alcohol Outpatient Licensing: BSAS Outpatient Services
Outpatient SUD treatment in Massachusetts runs through 105 CMR 164.200, and BSAS defines the sub-categories more precisely than a lot of operators expect going in — precise enough that guessing which one describes your program is a real risk.
Day Treatment has an actual hour requirement
Day Treatment isn’t a loose label in Massachusetts — it’s defined as an intensive outpatient program providing direct patient services through group, individual, and family SUD counseling for a minimum of 3.5 hours per day, at least three days a week. If your program doesn’t meet that threshold, BSAS isn’t going to consider it Day Treatment regardless of what you call it internally, and that mismatch matters when your marketing describes a level of care your licensed hours don’t support.
Outpatient Withdrawal Treatment Service is its own category
This is ambulatory SUD treatment that clinically manages withdrawal symptoms through medical and ancillary treatment without a 24-hour residential setting. It’s a distinct service type from Day Treatment and from the 24-Hour Diversionary Services covered under inpatient — don’t assume outpatient withdrawal management and Day Treatment share the same standards just because both happen outside a residential setting.
Opioid Treatment Programs and MAT access
OTPs fall under Part Two of 105 CMR 164 alongside the other specific service categories, and they carry their own Medical Director requirement, the same as 24-Hour Diversionary and Outpatient Withdrawal Management services. Massachusetts also has a nondiscriminatory-access requirement worth knowing regardless of whether you’re running a dedicated OTP: providers agree to offer access to all FDA-approved medications for opioid use disorder on a nondiscriminatory basis, consistent with the CARE Act of 2018’s broader nondiscrimination requirements around insurance type. This isn’t a narrow OTP-only rule — it reflects the same direction other states are moving in around guaranteed MAT access, and it’s worth building into your program design even if medication management isn’t your primary service line.
Accreditation can count toward compliance
Outpatient programs benefit from the same “Deemed Status” mechanism that applies across 105 CMR 164 — under 164.005, BSAS can accept accreditation from an approved organization, CARF and Joint Commission included, as evidence that a program already satisfies specific requirements. It’s not a substitute for the underlying license or the Notice of Intent process, but it can reduce duplicate review once BSAS confirms what your accreditation actually covers.
Central Registry System participation
If you’re operating an OTP specifically, amendments to 105 CMR 164.305 require participation in the Central Registry System — this was phased in with a 90-day implementation window when it took effect, and it’s an ongoing compliance obligation, not a one-time signup.
How We Help
We help Massachusetts operators classify their outpatient program correctly under 164.200, build MAT access into program design where it applies, and stay current on Central Registry and other BSAS compliance updates. See our Massachusetts Behavioral Health Licensing page for the full picture, or reach out for a free consultation.
This content is provided for general informational purposes only and should not be construed as medical, clinical, legal, financial, tax, accounting, insurance, licensing, accreditation, regulatory, billing, employment, or compliance advice. Requirements change often. Consult qualified professionals or contact Continued Compliance, Inc. for guidance specific to your situation. This article was created by the compliance expert cited above and reviewed by AI. A compliance expert approved and edited it for accuracy before publication.
Leave a Reply